Cookies on VetMed Resource

Like most websites we use cookies. This is to ensure that we give you the best experience possible.

 

Continuing to use www.cabi.org  means you agree to our use of cookies. If you would like to, you can learn more about the cookies we use.

VetMed Resource

Veterinary information to support practice, based on evidence and continuing education

Sign up to receive our Veterinary & Animal Sciences e-newsletter, book alerts and offers direct to your inbox.

Results per page:

Search results

Abstract

Background: CredelioTM (lotilaner) is an oral ectoparasiticide from the isoxazoline class developed for the treatment of flea and tick infestations in cats. It is formulated as a pure S-enantiomer in flavoured chewable tablets. The pharmacokinetics of lotilaner were investigated after intravenous...

Author(s)
Toutain, C. E.; Seewald, W.; Jung, M.
Publisher
BioMed Central Ltd, London, UK
Citation
Parasites and Vectors, 2018, 11, 412, pp (13 July 2018)
Abstract

Background: Lotilaner is approved for dogs as a chewable tablet formulation. It has separately been developed for oral administration in cats (CredelioTM chewable tablets for cats) to meet the need for an easy to use, safe and rapidly effective parasiticide and as an alternative to topical...

Author(s)
Cavalleri, D.; Murphy, M.; Seewald, W.; Nanchen, S.
Publisher
BioMed Central Ltd, London, UK
Citation
Parasites and Vectors, 2018, 11, 408, pp (13 July 2018)
Abstract

Background: A blinded, randomized, negative controlled laboratory study was conducted to evaluate the efficacy of lotilaner (CredelioTM, Elanco) when administered orally to dogs, against experimentally induced adult flea infestations and flea egg production. Methods: Twenty dogs were selected for...

Author(s)
Young, L.; Karadzovska, D.; Wiseman, S.; Helbig, R.
Publisher
BioMed Central Ltd, London, UK
Citation
Parasites and Vectors, 2020, 13, 25, pp (14 January 2020)
Abstract

Background: Lotilaner is a new isoxazoline developed as an oral ectoparasiticide for cats and dogs. Its safety, rapid killing onset of action and sustained speed of fleas and ticks kill for a minimum of one month after administration, were demonstrated in a number of laboratory studies in cats....

Author(s)
Cavalleri, D.; Murphy, M.; Seewald, W.; Nanchen, S.
Publisher
BioMed Central Ltd, London, UK
Citation
Parasites and Vectors, 2018, 11, 410, pp (13 July 2018)
Abstract

Background: There is a continuing need for novel approaches to tick infestations treatment and control in cats. Lotilaner, an isoxazoline with rapid onset of action, has proven its efficacy against ticks in laboratory studies. A study was undertaken to confirm lotilaner's efficacy and safety in...

Author(s)
Cavalleri, D.; Murphy, M.; Seewald, W.; Nanchen, S.
Publisher
BioMed Central Ltd, London, UK
Citation
Parasites and Vectors, 2018, 11, 411, pp (13 July 2018)
Abstract

Background: Lotilaner, approved for dogs as a chewable tablet formulation, has separately been developed for oral use in cats (CredelioTM chewable tablets for cats), to meet the need for an easy to use, safe and rapidly effective parasiticide. It is a valid cat- and owner-friendly alternative to...

Author(s)
Cavalleri, D.; Murphy, M.; Seewald, W.; Drake, J.; Nanchen, S.
Publisher
BioMed Central Ltd, London, UK
Citation
Parasites and Vectors, 2018, 11, 413, pp (13 July 2018)
Abstract

The most common fly species associated with screwworm myiasis in Southeast Asia is Chrysomya bezziana (Ch. bezziana), the Old-World screwworm. Treatment of screwworm myiasis in cats traditionally has comprised subcutaneous injection of ivermectin or oral administration of nitenpyram, combined with...

Author(s)
Han HockSiew; Yasmin, L.
Publisher
Wiley, Oxford, UK
Citation
Veterinary Dermatology, 2020, 31, 4, pp 335-e87
Abstract

Background: Lotilaner (CredelioTM) is the newest member of the novel isoxazoline chemical class to be developed to treat canine ectoparasitism. Administered orally, lotilaner is rapidly absorbed with peak blood levels occurring within 2 h post-treatment. A study was undertaken to determine the...

Author(s)
Cavalleri, D.; Murphy, M.; Seewald, W.; Drake, J.; Nanchen, S.
Publisher
BioMed Central Ltd, London, UK
Citation
Parasites and Vectors, 2017, 10, 521, pp (1 November 2017)
Abstract

Background: Lotilaner (CredelioTM, Elanco), a novel isoxazoline, is a systemic insecticide and acaricide that is rapidly absorbed following oral administration to dogs and has a half-life of 30 days. As part of a development program, studies were undertaken to investigate lotilaner's initial and...

Author(s)
Cavalleri, D.; Murphy, M.; Seewald, W.; Drake, J.; Nanchen, S.
Publisher
BioMed Central Ltd, London, UK
Citation
Parasites and Vectors, 2017, 10, 529, pp (1 November 2017)
Abstract

Background: Lotilaner is a new member of the isoxazoline class for treatment of flea and tick infestations in cats. This laboratory study with lotilaner vanilla-yeast flavoured chewable tablets (CredelioTM, Elanco) investigated the safety in healthy kittens starting at 8 weeks of age in a...

Author(s)
Kuntz, E. A.; Srinivas Kammanadiminti
Publisher
BioMed Central Ltd, London, UK
Citation
Parasites and Vectors, 2018, 11, 409, pp (13 July 2018)

Refine Results

Sort Order
Author
Geographical Location
Language
Organisms
Subject Topics